BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 26, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for March 5, 2020

March 5, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Align Technology, Alr Technologies, Ambra Health, Avita Medical, Biocartis Group, Bristol-Myers Squibb, Estar Technologies, Exocad Global Holdings, Forescout Technologies, Healthcare Information and Management Systems Society, Hewlett Packard, Hologic, Immersivetouch, Medigate, Okami Medical, Perspectum, Ra Medical, Regen Lab.
Read More

Appointments and advancements for March 5, 2020

March 5, 2020
New hires and promotions in the med-tech industry, including: Aspen Surgical Products, Cognoa, Dariohealth, Electromed, Neuronetics.
Read More

Regulatory actions for March 5, 2020

March 5, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allergan, Cardiol, Outlook, TG, Urovant, Zydus.
Read More

Other news to note for March 5, 2020

March 5, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allogene, Cellectis, City of Hope, Eleusis, Melinta, Scynexis, Servier.
Read More

In the clinic for March 5, 2020

March 5, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Arch, Auris, Debiopharm, Dynacure, Psioxus.
Read More

Financings for March 5, 2020

March 5, 2020
Biopharmas raising money in public or private financings, including: Baudax, Enlivex, Titan.
Read More

Appointments and advancements for March 5, 2020

March 5, 2020
New hires and promotions in the biopharma industry, including: Alligator, Fusion, Matinas, Rapt, Windmil.
Read More

Appointments and advancements for March 4, 2020

March 4, 2020
New hires and promotions in the med-tech industry, including: Anika Therapeutics, Charles River Laboratories International, Citiustech.
Read More

Regulatory actions for March 4, 2020

March 4, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Roche.
Read More

In the clinic for March 4, 2020

March 4, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Inflammatix, Ocutrx Vision Technologies.
Read More
Previous 1 2 … 1600 1601 1602 1603 1604 1605 1606 1607 1608 … 1724 1725 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing